New Hope for Obesity Treatment: Bimagrumab Update
Kilder
- Nature: Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial - Nature
- Nature: Establishing a commercial solution for extremely rare genetic diseases - Nature
- Nature: Harnessing genomics for early cancer detection, risk stratification and prevention - Nature
- Fiercebiotech: UniQure shares crash 40% as FDA rejects early approval path for Huntington's gene therapy - Fierce Biotech
- Fiercebiotech: FDA fully releases clinical hold on Intellia CRISPR trials - Fierce Biotech
- Fiercebiotech: Roche reports pivotal MS win, but deaths add to safety questions - Fierce Biotech
- wikimedia: Photo by National Center for Advancing Translational Sciences / Wikimedia Commons / Public domain
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.